Singapore markets close in 3 hours 52 minutes

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.3200-0.9700 (-22.61%)
At close: 04:00PM EDT
3.3400 +0.02 (+0.60%)
After hours: 07:57PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate-0.51-0.49-2.3-1.06
Low estimate-0.56-0.54-3.24-1.22
High estimate-0.46-0.42-1.61-0.78
Year ago EPS-0.8-1.63-3.83-2.3
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts771010
Avg. Estimate68.21M70.95M281.22M381.52M
Low estimate64M65.8M272.88M341M
High estimate72.83M75M288M406.96M
Year ago sales58.13M56.78M234.04M281.22M
Sales growth (year/est)17.30%25.00%20.20%35.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.78-0.85-0.72-0.75
Actual EPS-0.8-1.63-0.62-0.58
Difference-0.02-0.780.10.17
Surprise %-2.60%-91.80%13.90%22.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.51-0.49-2.3-1.06
7 days ago-0.51-0.49-2.3-1.06
30 days ago-0.51-0.49-2.3-1.06
60 days ago-0.51-0.49-2.3-1.06
90 days ago-0.47-0.47-1.9-0.91
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRVNCIndustrySector(s)S&P 500
Current qtr.36.30%N/AN/AN/A
Next qtr.69.90%N/AN/AN/A
Current year39.90%N/AN/AN/A
Next year53.90%N/AN/AN/A
Next 5 years (per annum)11.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A